Wang et al. [49] proposed that the effectiveness of Langchuangding (LCD) therapy in treating SLE may be due to its impact on the TLR7-IRF7-IFNα pathway, suggesting that IRF7 could be a potential target for SLE treatment. The gene discussed is IFNA1; the disease is systemic lupus erythematosus.